In an amended 13D filing on Aquinox Pharmaceuticals (Nasdaq: AQXP), hedge fund Baker Bros. Advisors disclosed a 39.8%, or 4,269,560 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE